CHRISTAL HOUSE: Open Payments
NPI 1568021038 · MONTICELLO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 104 payments from 22 companies in 2025. Trend: 2023 $2,731 · 2024 $2,165 · 2025 $2,049
Food & beverage: $2,049
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $419 |
| PFIZER INC. | 9 | $189 |
| Novo Nordisk Inc | 9 | $181 |
| Axsome Therapeutics, Inc. | 11 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $156 |
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| Lundbeck LLC | 5 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $106 |
| Lilly USA, LLC | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
Products named: VRAYLAR, REXULTI, CAPLYTA, QULIPTA, NURTEC ODT, Wegovy, Kerendia, Sunosi.
Industry payments across GA — which companies pay providers there.
